Torres ED, Domínguez MJ, Buenfil VL, Cicero AM

Language: Spanish
References: 23
Page: 44-49
PDF size: 355.07 Kb.

ABSTRACT

Health care associated infections (HCAI), formerly known as nosocomial infections, represent an important public health and hospital problem. The pattern of nosocomial infections recorded during 2015 in a high specialty regional hospital of Yucatan is presented.
Material and Method. Registration of health care associated infections was performed prospectively according to the criteria of NOM-045. We obtained the demographic and identification data of the patients, risk factors, location of the infection, isolated microorganisms and profile of resistance/susceptibility to antibiotics. The data is presented with descriptive statistics.
Results. From January to December 2015 there were 211 cases of HCAI, of which 41.3% (88) corresponded to women, the average age of all patients was 52 years. The average rate of HCAI for the hospital was 4.9% during 2015 and the most frequent locations were: surgical site, pneumonia associated with mechanical ventilation and urinary tract infection associated with urinary catheter. The services with the most hcai accumulated were: UCI-Adults, Internal Medicine, General Surgery and Cardiology. We obtained 236 bacterial isolates of which 37 corresponded to Pseudomonas aeruginosa, 33 to Escherichia coli, 31 to Staphylococcus aureus, 26 to Klebsiella pneumoniae and 11 to ESBL strains of E. coli. Only one isolate corresponded to extensively drug-resistant Pseudomonas aeruginosa. Among the fungi, the most common isolate was Candida albicans. There was a linear tendency towards the decrease of the rate for 100 expenses and the rate for one thousand days of stay when comparing 2015 with 2014.
Discussion and Conclusions. The HCAI rate in this hospital is below the national reference rate. The clinical characteristics of the patients, the location of the infections and the isolated microorganisms are similar to those described in other institutions.

REFERENCES

1. Sydnor, E.R.M. y Pearl, T.M., “Hospital epidemiology and infection control in acute-care settings”, Clin Microbiol Rev, 2011, 24 (1): 141-173.

2. Cardo, D., Dennehy, P.H., Halverson, P., Fishman, N., Kohn, M., Murphy, C.L. y Whitley, L.J., “Moving toward elimination of healthcare-associated infections: a call to action”, Am J Infect Control, 2010, 38: 671-675.

3. Chen, Y.Y., Chou, Y.C. y Chou, P., “Impact of nosocomial infection on cost of illness and length of stay in intensive care units”, Infect Control Hosp Epidemiol, 2005, 26: 281-287.

4. Ponce de León, S., “El problema de las infecciones hospitalarias”, en Macías, A. y De la Torre, A. (eds.), Manual para la prevención y el control de infecciones asociadas al cuidado de la salud, 1ª ed., México, Intersistemas, 2014. pp. 17-19.

5. Arreguín, R., González, R. y De la Torre, A., “Infecciones adquiridas en los hospitales. ¿Cuánto cuestan y cómo se calcula?”, Revista Digital Universitaria, 2012, 13 (9): 1-10, disponible en: http://www.revista.unam.mx/vol.13/ num9/art88/index.html.

6. Olaechea, P.M., Insausti, J., Blanco, A. y Luque, P., “Epidemiología e impacto de las infecciones nosocomiales”, Med Intensiva, 2010, 34 (4): 256-267.

7. World Health Organization, Prevention of hospital-acquired infections. A practical guide, Ducel, G., Fabry J. y Nicolle, L. (eds.), 2ª ed., Ginebra, 2002, pp. 4-62.

8. Delpiano, L., “Infecciones asociadas a la atención de salud: de Semmelweis a nuestros días, una historia de logros y desafíos”, Medwave, 2011, (11) doi: 10.5867/ medwave.2011.11.5256.

9. González Miranda, L. y Miranda Novales, G., “La importancia del comité de prevención y control de infecciones nosocomiales”, Enf Inf Microbiol, 2006, 26 (3): 82-85.

10. Secretaría de Salud, “Norma Oficial Mexicana (nom-045- ssa2-2005), para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales”, Diario Oficial de la Federación, 20/09/2009, disponible en: http:// dof.gob.mx/nota_detalle.php?codigo=5120943&fecha= 20/11/2009.

11. Red Hospitalaria de Vigilancia Epidemiológica, Informe anual 2014, Dirección General de Epidemiología, Secretaría de Salud, 2016, México. Disponible en: www.epidemiología. salud.gob.mx. (Consultado: 27 de septiembre de 2016).

12. Secretaría de Salud, Dirección General de Evaluación del Desempeño, “Medición de la prevalencia de infecciones nosocomiales en hospitales generales de las principales instituciones públicas de salud”, Informe documental en extenso, 2011: 3-67. 13.. Taylor, M.E. y Oppenheim, B.A., “Hospital-acquired infection in elderly patients”, J. Hosp. Infect, 1998, 38: 245-260.

13. Ferguson, J.K., Preventing healthcare-associated infection: risks, health care systems and behavior”, Intern Med, 2009, 39: 574-581.

14. Wenzel, R.P., “Importance of infection control”, en Bearman, G.M.L., Stevens, M., Edmond, M. y Wenzel, R., para la International Society for Infectious Diseases, A guide to infection control in the hospital, 5ª ed., Brookline, MA, 2014, pp. 1-5.

15. Peleg, A.Y. y Hooper, D.C., “Hospital-acquired infections due to gram-negative bacteria”, N Engl J Med, 2010, 362 (19): 1804-1813.

16. Cosgrove, S.E., “The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs”, Clin Infect Dis, 2006, 42 (Suppl. 2): S82-S89.

17. Schwaber, M.J., Navon-Venezia, S., Kaye, K.S. et al., “Clinical and economic impact of bacteremia with extende- spectrum-B-lactamase-producing Enterobacteriaceae”, Antimicrob Agents Chemother, 2006, 50 (4): 1257-1262.

18. Oteo, J., Pérez-Vázquez, M. y Campos, J., “Extended- spectrum B-lactamase producing Escherichia coli: changing epidemiology and clinical impact”, Curr Opin Infect Dis, 2010, 23: 320-326.

19. World Health Organization, “Step-by-step approach for development and implementation of hospital antibiotic policy and standard treatment guidelines”, 2011: 35-39.

20. Hamilton, K.W. y Fishman, N.O., “Antimicrobial stewardship interventions: thinking inside and outside the box”, Infect Dis Clin N Am, 2014, 28: 301-313.

21. Muller, A., López-Lozano, J.M., Bertrand, X. y Talon, D., “Relationship between ceftriaxona use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae”, J Antimicrobial Chemother, 2004, 54 (1): 173-177.

22. Davies, J. y Davies, D., “Origins and evolution of antibiotic resistance”, Microbiol Mol Biol Rev, 2010, 74 (3): 417-433.

23. Lister, P.D., Wolter, D.J. y Hanson, N.D., “Antibacterial-resistant pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms”, Clin Microbiol Rev, 2009, 22 (4): 582-610.